Actonel and Viith nerve paralysis - a phase IV clinical study of FDA data

Summary:

Viith nerve paralysis is reported as a side effect among people who take Actonel (risedronate sodium), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Fosamax, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Viith nerve paralysis when taking Actonel. It is created by eHealthMe based on reports of 28,929 people who have side effects when taking Actonel from the FDA, and is updated regularly.

What is Actonel?

Actonel has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 29,369 Actonel users. Check the latest studies of Actonel.

What is Viith nerve paralysis?

Viith nerve paralysis is found to be associated with 525 drugs and 837 conditions by eHealthMe. Check the latest studies of Viith nerve paralysis.

On Aug, 07, 2026

28,929 people reported to have side effects when taking Actonel.
Among them, 40 people (0.14%) have Viith nerve paralysis.

Could Actonel cause Viith nerve paralysis?

Among these 40 people:

How long have people been on Actonel when they have Viith nerve paralysis? *

What is the gender of people who have Viith nerve paralysis when taking Actonel? *

female: 94.59 %
male: 5.41 %

What is the age of people who have Viith nerve paralysis when taking Actonel? *

What are other drugs people take besides Actonel? *

What are other side effects people have besides Viith nerve paralysis? *

Tooth Abscess (pus formation in tooth): 23 people, 57.50%
Osteonecrosis Of Jaw (death of bone of jaw): 22 people, 55.00%
Fall: 19 people, 47.50%
Cough: 18 people, 45.00%
Tooth Disorder (tooth disease): 17 people, 42.50%
Impaired Healing: 17 people, 42.50%
Weakness: 16 people, 40.00%
Tooth Fracture: 16 people, 40.00%
Rashes (redness): 16 people, 40.00%
Stress And Anxiety: 16 people, 40.00%

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 25.00%
Fatigue (feeling of tiredness): 9 people, 22.50%
Multiple Myeloma (cancer of the plasma cells): 9 people, 22.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 17.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 17.50%
High Blood Cholesterol: 6 people, 15.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.00%
Diabetes: 3 people, 7.50%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.50%

* Approximation only. Some reports may have incomplete information.

Do you take Actonel and have Viith nerve paralysis?

- Check whether Viith nerve paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actonel:

Actonel (29,369 reports)

Browse all side effects of Actonel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Viith nerve paralysis:

Viith nerve paralysis (525 drugs)

Browse all the conditions that are associated with Viith nerve paralysis:

Viith nerve paralysis (837 conditions)

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Actonel) and Actonel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.